Adherence to surveillance endoscopy following hospitalization for index esophageal variceal hemorrhage

Table 1 Summary of baseline patient characteristics n (%)

Demographics/baseline measures	Number (n = 99)
Male	59 (60)
Age, median (range), yr	55 (31-82)
Etiology of cirrhosis
Alcohol	62 (63)
Hepatitis C	12 (12)
Other	25 (25)
Recent alcohol use	46 (46)
Distance from hospital, median (range), kilometers	24.9 (0.8-95.1)
MELD score, median (range)	13 (6-27)
Child-turcotte-pugh classification
A	24 (24)
B	53 (54)
C	22 (22)
Index bleed in 2007 or earlier	44 (44)
Insurance
Medicaid1 or uninsured	31 (31)
Medicare or private insurance	68 (69)
Comorbid psychiatric disorder	39 (39)
Length of stay, median (range), d	5 (2-75)
Beta-blocker at discharge	86 (87)

¹Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease.

Table 2 Outcomes of the study population n (%)

Demographics/baseline measures	Number (n = 99)
Incomplete obliteration	66 (66)
No post-discharge endoscopy	46 (46)
Completed obliteration	33 (33)
Adhered to 1-yr surveillance	12 (12)
Rehospitalized for variceal bleed	46 (46)

Table 3 Characteristics of those completing variceal obliteration n (%)

Measures	Obliteration (n = 33)	No obliteration (n = 66)	P value
Male	18 (55)	41 (62)	0.5186
Age, median (range), yr	53 (34-78)	54 (31-82)	0.3934
Etiology of cirrhosis
Alcohol	19 (58)	43 (65)	0.5125
Hepatitis C	4 (12)	8 (12)	1.0000
Other	10 (30)	15 (23)	0.4657
Recent alcohol use	15 (45)	31 (47)	1.0000
Distance from hospital, median (range), kilometers	24.9 (0.8-80.3)	20.9 (1.4-95.1)	0.6892
MELD score, median (range)	12 (6-18)	13.5 (7-27)	0.1615
Child-turcotte-pugh classification
A	11 (33)	13 (20)	0.1451
B	17 (52)	36 (54)	0.8325
C	5 (15)	17 (26)	0.3080
Index bleed in 2007 or earlier	15 (45)	29 (44)	1.0000
Medicaid1 or uninsured	7 (21)	24 (36)	0.1687
Comorbid psychiatric disorder	9 (27)	30 (45)	0.1260
Length of stay, median (range), d	6 (2-33)	5 (3-75)	0.5619
Beta-blocker at discharge	30 (91)	56 (85)	0.5348

¹Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease.

Table 4 Characteristics of those completing variceal obliteration and surveillance at 1-yr intervals n (%)

Measures	1-yr surveillance (n = 12)	Incomplete adherence (n = 87)	P value
Male	7 (58)	52 (60)	1.0000
Age, median (range), yr	55 (45-78)	54 (31-82)	0.1936
Etiology of cirrhosis
Alcohol	6 (50)	56 (64)	0.3560
Hepatitis C	2 (17)	10 (12)	0.6364
Other	4 (33)	21 (24)	0.4918
Recent alcohol use	15 (45)	42 (48)	0.3726
Distance from hospital, median (range), kilometers	30.4 (3.7-80.3)	13.7 (0.8-95.1)	0.3898
MELD score, median (range)	11.5 (6-17)	13 (7-27)	0.2543
Child-turcotte-pugh classification
A	3 (25)	21 (24)	1.0000
B	6 (50)	47 (54)	1.0000
C	3 (25)	19 (22)	0.7259
Index bleed in 2007 or earlier	2 (17)	42 (48)	0.0607
Medicaid1 or uninsured	0 (0)	31 (36)	0.0160
Comorbid psychiatric disorder	5 (42)	34 (39)	1.0000
Length of stay, median (range), d	6 (3-7)	5 (2-75)	0.8808
Beta-blocker at discharge	12 (100)	74 (85)	0.3572

¹Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease.

Table 5 Characteristics of those adherent to surveillance at 1-yr intervals vs no endoscopic follow up n (%)

Measures	1-yr surveillance (n = 12)	No post-discharge EGD (n = 46)	P value
Male	7 (58)	29 (63)	0.7518
Age, median (range), yr	55 (45-78)	54.5 (31-82)	0.4237
Etiology of cirrhosis,
Alcohol	6 (50)	28 (61)	0.5273
Hepatitis C	2 (17)	6 (13)	0.6649
Other	4 (33)	12 (26)	0.7200
Recent alcohol use	4 (33)	21 (46)	0.5255
Distance from hospital, median (range), kilometers	30.4 (3.7-80.3)	20.9 (1.5-95.1)	0.4965
MELD score, median (range)	11.5 (6-17)	13 (7-26)	0.1707
Child-turcotte-pugh classification
A	3 (25)	9 (20)	0.6983
B	6 (50)	27 (59)	0.7455
C	3 (25)	10 (21)	1.0000
Index bleed in 2007 or earlier	2 (17)	19 (41)	0.1790
Medicaid1 or uninsured	0 (0)	17 (37)	0.0119
Comorbid psychiatric disorder	5 (42)	19 (41)	1.0000
Length of stay, median (range), d	6 (3-7)	5 (3-75)	0.6455
Beta-blocker at discharge	12 (100)	38 (80)	0.1851

¹Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease; EGD: Esophagogastroduodenoscopy.